Home > PE Ratio > PIRAMAL PHARMA

PIRAMAL PHARMA
PE (Price/Earnings) Ratio

The Current P/E Ratio of PIRAMAL PHARMA is -1,532.19.

Share Price ₹234.9Jan 14,2025
Market Cap ₹31,134.1 Cr
Earnings-TTM₹-20.3 CrTTM-Consolidated Results
Price/Earnings-1,532.19xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of PIRAMAL PHARMA

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of PIRAMAL PHARMA is calculated as :

Current Market Cap [ ₹31,134.1 Cr] as on Jan 14,2025

(/) Earnings [ ₹-20.3 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ -1,532.19x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for PIRAMAL PHARMA , the investors are currently willing to pay -1,532.19 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PIRAMAL PHARMA !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of PIRAMAL PHARMA over the last five years.

Historical PE (Price/Earnings) ratio chart of PIRAMAL PHARMA


PE Ratio Performance Analysis for PIRAMAL PHARMA

- PIRAMAL PHARMA 's latest p/e ratio is -1,532.19x.

- PIRAMAL PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2021 averaged 239.24x.

- PIRAMAL PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 4 fiscal years, PIRAMAL PHARMA 's p/e ratio peaked in Mar2024 at 956.94x.

- PIRAMAL PHARMA 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does PIRAMAL PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
PIRAMAL PHARMA -20.32-1,532.1931,134.1
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5038.11424,382.0
CIPLA LTD4,485.2226.07116,943.0
DR REDDYS LABORATORIES LTD5,406.8020.64111,588.0
ZYDUS LIFESCIENCES LTD4,298.9023.43100,704.0
DIVIS LABORATORIES LTD1,836.0086.72159,224.0
MANKIND PHARMA LTD2,124.8651.87110,215.0
TORRENT PHARMACEUTICALS LTD1,802.0061.12110,142.0
LUPIN LTD2,651.9437.0898,330.0
AUROBINDO PHARMA LTD3,598.8318.9668,238.4
ABBOTT INDIA LTD1,284.6646.7460,041.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PIRAMAL PHARMA 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -1.00x
Max industry PE 86.72x
Median industry PE 37.08x
Average industry PE 37.25x



You may also like the below Video Courses